---

$26.42

-3.9800 ( -13.10% ) 1.8M

Capricor Therapeutics Inc is a United States-based biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy and other medical conditions. The company's development stage product pipeline includes CAP-1002, for Duchenne Muscular Dystrophy Program and COVID-19 Program; CDC-Exosomes (CAP-2003); and Exosome-mRNA vaccine.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2023-10-06	Buy	2500.00	Musket David B
2023-09-06	Sale	-115000.00	Kelliher Mike
2023-08-16	Sale	-20748.00	Litvack Frank